Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Cancers (Basel). 2022 May 4;14(9):2293. doi: 10.3390/cancers14092293.
Cancers (Basel). 2022.
PMID: 35565422
Free PMC article.
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
Iacovelli R, Ciccarese C, Maruzzo M, Atzori F, Galli L, Scagliarini S, Massari F, Verzoni E, Cannella A, Maratta MG, Caserta C, Bimbatti D, Deppieri FM, Dessi M, Paolieri F, Riccardi F, Bracarda S, De Giorgi U, Basso U, Tortora G, Procopio G.
Iacovelli R, et al. Among authors: deppieri fm.
Clin Genitourin Cancer. 2022 Oct;20(5):498.e1-498.e9. doi: 10.1016/j.clgc.2022.06.006. Epub 2022 Jun 9.
Clin Genitourin Cancer. 2022.
PMID: 35768316
Item in Clipboard
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report.
Dionese M, Pierantoni F, Maruzzo M, Bimbatti D, Deppieri FM, Maran M, Gardiman MP, Basso U.
Dionese M, et al. Among authors: deppieri fm.
Anticancer Drugs. 2021 Feb 1;32(2):222-225. doi: 10.1097/CAD.0000000000000991.
Anticancer Drugs. 2021.
PMID: 32868643
Item in Clipboard
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature.
Bimbatti D, Maruzzo M, Pierantoni F, Diminutto A, Dionese M, Deppieri FM, Lai E, Zagonel V, Basso U.
Bimbatti D, et al. Among authors: deppieri fm.
Crit Rev Oncol Hematol. 2022 Feb;170:103579. doi: 10.1016/j.critrevonc.2022.103579. Epub 2022 Jan 7.
Crit Rev Oncol Hematol. 2022.
PMID: 35007699
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.